Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 690 results for "sun pharma advanced research"

Pharmaceutical Newsletter - July 18 to 22, 2016
India Infoline

Sun Pharma unit looks to get epilepsy drug on sales track

India's Sun Pharma Advanced Research Company (SPARC) has licensed its novel epilepsy drug Elepsia XR (levetiracetam) to its parent, Mumbai-based Sun Pharmaceutical Industries, as a way to speed up U.S. market entry following manufacturing issues ... FiercePharma, 5 days ago
Pharmaceutical Newsletter - July 18 to 22, 2016 India Infoline, 3 days ago
[x]  

40 images for sun pharma advanced research

Business Standard India, 1 week ago
India Infoline, 2 months ago
Business Standard India, 1 week ago
Financial Express, 1 week ago
The Freepress Journal, 1 week ago
India Infoline, 3 days ago
India Infoline, 1 week ago
India Infoline, 4 months ago
Indian Express, 1 week ago
India Infoline, 2 months ago

SPARC Licenses Epilepsy Drug to Sun Pharma

Sun Pharma Advanced Research Company and Sun Pharma announced a licensing arrangement for SPARC's ELEPSIA XRTM (Levetiracetam Extended Release tablets). As per the agreement, SPARC will license ELEPSIA XRTM (Levetiracetam Extended Release ...
 PharmaAsia5 days ago SPARC jumps after entering into licensing arrangement with Sun Pharma  Business Standard1 week ago Sun Pharma partners SPARC to market epilepsy drug in US  Livemint.com1 week ago
[x]  
Financial Express

SPARC gains over 7 per cent intraday on licence pact

MUMBAI: Shares of Dilip Shanghvi-promoted Sun Pharma Advance Research Company (SPARC) jumped more than 7 per cent in Monday's trading, after the company announced that it will out-license its anti-epileptic drug ELEPSIA to Sun Pharmaceutical ...
 Economic Times6 days ago SPARC shares surge over 7% intraday on inking licensing pact with Sun Pharma  Financial Express1 week ago SPARC shares surge over 7% on inking licensing pact with Sun Pharma  NewsFlow241 week ago
IndUS Business Journal

Sun Pharma gets epilepsy drug licence for US market

Chennai, July 18 (IANS): Sun Pharmaceutical group on Monday announced the licensing of ELEPSIA XR drug by Sun Pharma Advanced Research Company Ltd (SPARC) to a subsidiary of Sun Pharmaceutical Industries Ltd for the US market. In a statement, Sun ...
 Daijiworldcom1 week ago
[x]  

Buy SPARC, Magma Fincorp, Balrampur Chini, JK Lakshmi: Gujral

Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharma Advance Research Company, Magma Fincorp, Balrampur Chini and JK Lakshmi Cement.
 Money Control3 weeks ago Buy Sun Pharma Advanced, Mercator, MM Financial: Ashwani Gujral  Money Control3 weeks ago Buy Dena Bank, SREI Infra, Biocon, Sun Pharma Adv: Gujral  Money Control3 weeks ago

Pick ICICI Bank, SPARC, GIC Housing: Vijay Chopra

Vijay Chopra of enochventures.com is of the view that one may pick ICICI Bank and Sun Pharma Advanced Research Company.
 Money Control3 weeks ago Sensex, Nifty50 jumpy; ICICI Bank, Infosys, HDFC Bank top gainers  Economic Times1 month ago Sensex, Nifty50 start flat; ICICI Bank, Infosys, HDFC Bank top gainers  Economic Times1 month ago
Rediff.com

Sensex advances 128 points on pharma booster dose

Markets advanced for a second day as the BSE Sensex gained 128 points to 27,915, mainly led by pharmaceutical stocks after three Indian firms received nod to sell their generic versions of blockbuster Crestor drug in the American market. Sentiment also remained buoyant as a good monsoon season so far lifted hopes of a revival in farm output as well as income and on optimism over the Goods and Services Tax bill's passage. Shares of Sun Pharma, Glenmark and Aurobindo were the star performers, ...
 Rediff.com5 days ago Sensex advances 128 pts on pharma booster dose  Press Trust of India5 days ago Stock markets advance on pharma dose  The Freepress Journal5 days ago Sensex advances 128 pts on ph...  The Echo Of India3 days ago
[x]  

Sensex advances on pharma booster dose

Sensex opened slightly lower at 27,775.70 and moved between 27,935.18 and 27,759.71, before ending at 27,915.89, showing a rise of 128.27 points. Market advanced for a second day as the BSE Sensex gained 128.27 points to 27,915.89, mainly led by ...
 The Hindu5 days ago
IOL Business Report

Big Pharma drawn back to antibiotics

File picture. Credit: SXC.HU With the planet on the brink of losing its miracle cures for bacterial diseases, research incentives from governments are spurring drugmakers to renew efforts to fight antimicrobial resistance and replenish the ...
 IOL Business Report3 weeks ago There's Big Money Again in Saving Humanity With Antibiotics  PharmaVOICE3 weeks ago Superbugs and Subsidies Draw Big Pharma Back to Antibiotics  Bloomberg3 weeks ago Superbugs, subsidies draw big pharma back to antibiotics  Business Mirror3 weeks ago
[x]  
Bloomberg

Indian Pharma Tycoons Foray Into New Drugs to Shore Up Growth

Indian drugmakers are embarking on a research spending spree to master more complex therapies and their billionaire founders look willing to absorb the costs. The goal? To reach more people like Ryan Matzner, an asthma patient who lives thousands ...
 Bloomberg1 month ago Net sales of 100 top pharma cos move up by 10.3% to Rs. 1.9 lakh crore in 2015-16  PharmaBiz3 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharma advanced research
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less